Judge rejects Kenvue (KVUE) bid to dismiss Texas attorney general's lawsuit over marketing of Tylenol, according to a court order
Context
The rejection of Kenvue's motion to dismiss the lawsuit from the Texas attorney general indicates potential legal challenges ahead for the company regarding the marketing practices of Tylenol. This could heighten regulatory scrutiny and might lead to settlements or changes in marketing strategy, impacting investor sentiment and stock performance in the sector.
Trade the TapeGet this analysis live, the moment it breaksNewsquawk's real-time dashboard delivers market-moving headlines and instant context to your desk before the rest of the market reacts.
Open Dashboard#ATTORNEY GENERAL#EQUITIES#EU SESSION#US SESSION#PERSONAL CARE PRODUCTS#PERSONAL CARE PRODUCTS (GROUP)#HOUSEHOLD & PERSONAL PRODUCTS#S&P 500 INDEX#KENVUE INC#KVUE#US EQUITIES